CD274 and neoplasm: After the treatments of SK-BR-3 cells with PD-1/Fc (1 μg/ml) or IFN-γ (100 ng/ml), carried out for 72 hours at 37 °C, we analysed the effects on both tumor cell survival and on the pathways downstream PD-L1.